AzTrials
AzTrials

Eating DisordersEDCRNNCT06537895

Eating Disorders Clinical Research Network

An observational study of Eating Disorders, run by King's College London.

Unknown status

Status not confirmed. The sponsor has not verified this record for over two years, so it may be out of date.

Official record
Search all trials

Trial summary

UK Eating Disorder services are facing unprecedented demand, with effective service delivery hampered by inadequate resources, fragmented services and variable care pathways. Individuals with eating disorders, families and clinicians all agree on the critical need to improve care pathways and treatment, leading to… Read more about this study

Who is it for?
Ages 8 to 100 years
Conditions the study is for
Eating Disorders
What is being tested?
EDCRN questionnaires
How many people
12,000 participants
Where
No sites listed yet
Study dates
1 Oct 2024to 29 Oct 2026
Phase
Observational
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 8 to 100 years
  • All sexes
  • Child, Adult, Older adult

Study population: The study population are individuals who are receiving treatment for an eating disorder(s) at a UK-based eating disorder service which is part of the EDCRN and (if desired by the patient and caregiver) their parents/guardians.

Who may be able to join

  • Patients who have been diagnosed with an eating disorder under at least 1 of the criteria specified in the DSM-5 and/or ICD-9, 10 or 11.
  • Patients who are receiving treatment as inpatients, day-patients or outpatients at a CAMHS or Adult service who is participating in the EDCRN.
  • Patients who are receiving treatment in the UK.
  • OR:
  • Parents/guardians of patients who have been diagnosed with an eating disorder under at least 1 of the criteria specified in the DSM-5 and/or ICD-9, 10 or 11.
  • Parents/guardians of patients who are receiving treatment as inpatients, day-patients or outpatients at a CAMHS or Adult service who is participating in the EDCRN.
  • Parents/guardians of patients who are receiving treatment in the UK.

Who cannot join

  • Individuals who do not meet the criteria specified above will be considered ineligible to participate in the EDCRN.

Trial locations and contacts

No sites are listed yet.

About this study

UK Eating Disorder services are facing unprecedented demand, with effective service delivery hampered by inadequate resources, fragmented services and variable care pathways. Individuals with eating disorders, families and clinicians all agree on the critical need to improve care pathways and treatment, leading to better outcomes.

Eating disorders are serious, complex conditions influenced by a blend of biological, psychological, and environmental factors. The approach of this project is grounded in the "biopsychosocial" model. Recently, anorexia research confirms a genetic component, with biological, metabolic, and psychological mechanisms at play. Further biological research across eating disorders could allow a better understanding of the mechanisms underlying eating disorder development and better, more personalised treatments.

Read more

This project will test the feasibility of establishing a UK-wide NHS research network spanning child and adult eating disorder services to enable a step change in the ability to conduct eating disorder research. It will help address fragmentation and facilitate novel biological, psychological, and social research collaborations. The data the investigators gather will be open to all researchers for data analyses, and the collaborations established will form a collaborative network to enable future clinical trials, experimental medicine and psychology.

The study will be conducted at child and adult eating disorder services who opt to join the Network. Participants will be patients receiving treatment for an eating disorder at one of the participating services, and their parents/guardians if applicable.

Participants will complete questionnaires and have blood and other physical tests as specified in the EDCRN dataset. The study will last until 29th October 2026 (the end of the current funding period) and/or when a participant is discharged from treatment, whichever is sooner. For participants discharged before the study ends, there will be an opportunity for patients to complete optional follow-up questionnaires on a periodic basis.

Being tested
EDCRN questionnaires
Medical subject headings
Feeding and Eating Disorders

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • EDCRN questionnairesOther

    Participants will complete questionnaires and have blood and other physical tests as specified in the EDCRN dataset.

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. EDCRN dataset

    The existence of a well-described dataset (maintained by at >50% eating disorder services across the UK) of eating disorder presentation, treatment, outcomes, demographics, social risk factors, and blood test results which can be accessed (with appropriate permissions) by researchers and others for the purposes of addressing novel research questions and facilitating service improvement efforts.

    The EDCRN dataset comprises the following parameters:

    • ED Behaviours/cognitions
    • Depression
    • Anxiety
    • Autism
    • OCD
    • Perfectionism
    • Emotional regulation
    • Psychosocial impairment
    • Adverse experiences
    • Self-injurious behaviour
    • Food insecurity
    • Physical/somatic symptoms
    • ADHD
    • Alcohol use
    • PTSD symptoms
    • Self-administered comorbidity
    • Weight stigma
    • Treatment experience
    • Comorbidities
    • Caregiver impact
    • Weight history
    • Muscle power
    • Endocrine function
    • Liver function
    • Cardiac function
    • Electrolytes
    • Bone health
    • Demographics

    Measured: 29th October 2026

Secondary outcomes (3)
  1. Data on treatment effects

    Data which provides insights into treatment moderators and mediators for different demographic groups.

    Measured: 29th October 2026

  2. Genetic Biomarkers

    Indicators of genetic biomarkers of treatment response.

    Measured: 29th October 2026

  3. Socio-economic influences

    Data which indicates socio-economic factors (e.g. the local food environment) influencing ED development, maintenance and outcomes.

    Measured: 29th October 2026

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted5 Aug 2024
  2. Study start1 Oct 2024 (estimated)
  3. Primary completion29 Oct 2026 (estimated)
  4. Study completion29 Oct 2026 (estimated)

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Observational
Observational model
Cohort
Time perspective
Prospective
Enrolment
12,000 participants (estimated)
IDs, dates and publications
ClinicalTrials.gov ID
NCT06537895
Sponsor's protocol ID
RE22072
Other IDs
MR/X030539/1, 341570
Acronym
EDCRN
Status last verified
Jul 2024
First submitted
23 Jul 2024
Last updated
5 Aug 2024
Results posted
No
Data monitoring committee
Yes
FDA-regulated drug
No
FDA-regulated device
No

Questions about this trial

What is this clinical trial studying?

An observational study of Eating Disorders, run by King's College London.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 7 inclusion and 1 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: status not confirmed, as of the sponsor's last update on 5 Aug 2024. Status can change between updates, so confirm with the study contact before making plans.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

Results are not available in the source record.

How can a doctor refer a patient or contact the research team?

Contact Anna Carnegie (020 7836 5454, anna.carnegie@kcl.ac.uk), or a site near the patient. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

EDCRN dataset (time frame: 29th October 2026). It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 5 Aug 2024.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in